KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Gross Margin (2018 - 2025)

BioNTech SE's Gross Margin history spans 8 years, with the latest figure at 798.38% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 89838.0% to 798.38% in Q4 2025 year-over-year; TTM through Dec 2025 was 60.26%, a 3972.0% decrease, with the full-year FY2025 number at 77.64%, up 48830.0% from a year prior.
  • Gross Margin hit 798.38% in Q4 2025 for BioNTech SE, down from 90.24% in the prior quarter.
  • Over the last five years, Gross Margin for BNTX hit a ceiling of 99.99% in Q4 2024 and a floor of 879.49% in Q2 2025.
  • Historically, Gross Margin has averaged 44.26% across 5 years, with a median of 79.9% in 2021.
  • The widest YoY moves for Gross Margin: up 28496bps in 2025, down -93302bps in 2025.
  • Tracing BNTX's Gross Margin over 5 years: stood at 89.46% in 2021, then rose by 7bps to 95.71% in 2022, then decreased by -8bps to 87.89% in 2023, then rose by 14bps to 99.99% in 2024, then plummeted by -898bps to 798.38% in 2025.
  • Business Quant data shows Gross Margin for BNTX at 798.38% in Q4 2025, 90.24% in Q3 2025, and 879.49% in Q2 2025.